Cargando…
Risk factors for the exacerbation of patients with 2019 Novel Coronavirus: A meta-analysis
Many studies have reported the risk factors for exacerbations in patients with 2019 novel coronavirus (2019-nCoV). This study aims to perform the meta-analysis of risk factors for the exacerbation of the novel coronavirus-infected pneumonia (NCIP). PubMed, Embase and Google scholar have been searche...
Autores principales: | Zhao, Jinqiu, Li, Xiaosong, Gao, Yao, Huang, Wenxiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7378653/ https://www.ncbi.nlm.nih.gov/pubmed/32714077 http://dx.doi.org/10.7150/ijms.47052 |
Ejemplares similares
-
Potential risk factors for case fatality rate of novel coronavirus (COVID-19) in China: A pooled analysis of individual patient data
por: Zhao, Jinqiu, et al.
Publicado: (2020) -
Ginsenoside Rg1 alleviates acute liver injury through the induction of autophagy and suppressing NF-κB/NLRP3 inflammasome signaling pathway
por: Zhao, Jinqiu, et al.
Publicado: (2021) -
Inflammation as an exacerbation marker and target for prophylaxis against Coronavirus Disease 2019-related thrombosis
por: Ono, Daisuke, et al.
Publicado: (2023) -
Exacerbation of livedoid vasculopathy after Coronavirus disease 2019
por: Kawabe, Ryoko, et al.
Publicado: (2022) -
The effect of coagulation factors in 2019 novel coronavirus patients: A systematic review and meta-analysis
por: Xiang, Guiling, et al.
Publicado: (2021)